Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256


Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.

Gendron L, Esdaile MJ, Mennicken F, Pan H, O'Donnell D, Vincent JP, Devi LA, Cahill CM, Stroh T, Beaudet A.

Neuroscience. 2007 Jan 5;144(1):263-74. Epub 2006 Oct 19.


Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.

Beaudry H, Proteau-Gagné A, Li S, Dory Y, Chavkin C, Gendron L.

Neuroscience. 2009 Jun 30;161(2):381-91. doi: 10.1016/j.neuroscience.2009.03.053. Epub 2009 Mar 27.


Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.

Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, Hoffert C, Mennicken F, Stroh T, Sadikot AF, O'Donnell D, Clarke PB, Collier B, Henry JL, Vincent JP, Beaudet A.

J Neurosci. 2004 Jun 16;24(24):5549-59.


Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control.

Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A.

Pain. 2003 Jan;101(1-2):199-208.


Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.

Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL, Beaudet A.

J Neurosci. 2003 Jun 15;23(12):4888-98.


Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.

Chen SR, Pan HL.

Neuropharmacology. 2008 Aug;55(2):215-22. doi: 10.1016/j.neuropharm.2008.05.011. Epub 2008 May 22.


Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Gendron L, Pintar JE, Chavkin C.

Neuroscience. 2007 Dec 19;150(4):807-17. Epub 2007 Oct 5.


Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.

Morinville A, Cahill CM, Kieffer B, Collier B, Beaudet A.

Pain. 2004 Jun;109(3):266-73.


Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord.

Labuz D, Chocyk A, Wedzony K, Toth G, Przewlocka B.

Life Sci. 2003 Jun 13;73(4):403-12.


Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.

Sykes KT, White SR, Hurley RW, Mizoguchi H, Tseng LF, Hammond DL.

J Pharmacol Exp Ther. 2007 Aug;322(2):813-21. Epub 2007 May 9.


Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.

Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A.

J Neurosci. 2001 Oct 1;21(19):7598-607.


Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.

Lee BS, Jun IG, Kim SH, Park JY.

J Korean Med Sci. 2012 Apr;27(4):430-6. doi: 10.3346/jkms.2012.27.4.430. Epub 2012 Mar 21.


Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia.

Luo MC, Chen Q, Ossipov MH, Rankin DR, Porreca F, Lai J.

J Pain. 2008 Dec;9(12):1096-105. doi: 10.1016/j.jpain.2008.06.005. Epub 2008 Oct 31.


Antinociceptive effects of isoleucine derivatives of deltorphin I and deltorphin II in rat spinal cord: a search for selectivity of delta receptor subtypes.

Labuz D, Toth G, Machelska H, Przewlocka B, Borsodi A, Przewłocki R.

Neuropeptides. 1998 Dec;32(6):511-7.


Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.

Szentirmay AK, Király KP, Lenkey N, Lackó E, Al-Khrasani M, Friedmann T, Timár J, Gyarmati S, Tóth G, Fürst S, Riba P.

Brain Res Bull. 2013 Jan;90:66-71. doi: 10.1016/j.brainresbull.2012.09.006. Epub 2012 Sep 17.


Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.

Schiene K, De Vry J, Tzschentke TM.

J Pharmacol Exp Ther. 2011 Nov;339(2):537-44. doi: 10.1124/jpet.111.181263. Epub 2011 Aug 4.


Antinociceptive and morphine modulatory actions of spinal orphanin FQ.

Jhamandas KH, Sutak M, Henderson G.

Can J Physiol Pharmacol. 1998 Mar;76(3):314-24.


Persistent pain model reveals sex difference in morphine potency.

Wang X, Traub RJ, Murphy AZ.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R300-6. Epub 2006 Feb 23.

Supplemental Content

Support Center